Moreover, several clinical studies using tumor genome sequencing showed MRP4 expression as a prognosis marker in esophageal [15], gastric [16], rectal [17], lung [18], ovarian [19] and prostate [20] cancer as well as in neuroblastoma [21]. This evidence concerns the gene ABCC4 and cancer.